ExlService Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ExlService Holdings, Inc. on August 27, 2021. The filing reports the termination of a material definitive agreement and the unregistered sale of equity securities related to the settlement of outstanding convertible notes.
Key Financial Metrics and Transaction Details
The Company settled its obligations under $150,000,000 aggregate principal amount of 3.50% Convertible Senior Notes due October 1, 2024. The settlement terms included:
- Cash Payment: $200 million paid to Orogen Echo LLC, plus accrued and unpaid interest through August 26, 2021.
- Equity Issuance: 310,394 shares of common stock issued directly to Orogen, calculated using a 20-day volume weighted average price ending August 26, 2021.
- Funding Source: The cash payment was funded by drawing on the Company's existing Credit Agreement with Citibank N.A. and other lenders.
Material Changes
As of August 27, 2021, the Indenture governing the Notes has been satisfied and discharged. The Investment Agreement dated October 1, 2018, between the Company and Orogen has been terminated. Consequently, Orogen is no longer entitled to nominate a member of the Board of Directors, though its current nominee, Mr. Vikram Pandit, will continue to serve subject to the Company's by-laws.
Outlook, Risks, and Unusual Items
The issuance of common stock was made pursuant to the exemption from registration requirements provided by Section 3(a)(9) of the Securities Act. Orogen agreed to a 90-day lock-up period regarding the transferability of the shares issued in this transaction. The filing does not provide updated revenue, profit, or margin guidance, as it focuses solely on the debt settlement event.
Key Facts for Investor Verification
- Verify the impact of the $200 million cash outflow on the Company's remaining liquidity and available credit under the Credit Agreement.
- Confirm the dilution effect of the 310,394 newly issued shares on existing shareholders.
- Review the terms of the 90-day lock-up agreement for the shares issued to Orogen.
- Assess the change in Board composition rights following the termination of the Investment Agreement.